Exploring potential drugs for amyotrophic lateral sclerosis in Chinese medicine based on data mining and Mendelian randomisation
- Conditions
- Amyotrophic lateral sclerosis
- Registration Number
- ChiCTR2400088835
- Lead Sponsor
- Shaanxi Provincial Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
? Patients who meet the diagnostic standards of Western medicine and are diagnosed with ALS; <br>? Aged 30-85 years old; <br>? Complete clinical data, especially complete biochemical examination data before and after taking traditional Chinese medicine.
?Cases where the diagnosis and outcome are unclear, information is missing or safety is in doubt; <br>?Those with incomplete medication information and clinical data; <br>?Patients with comorbidities such as hypertension, diabetes, and other diseases that may affect kidney function;<br>?Patients with a combination of acute and chronic liver and kidney function abnormalities, malignant tumours and other diseases.<br>
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum creatinine;
- Secondary Outcome Measures
Name Time Method